These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11483881)

  • 21. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
    McMurray JJ; Teerlink JR; Cotter G; Bourge RC; Cleland JG; Jondeau G; Krum H; Metra M; O'Connor CM; Parker JD; Torre-Amione G; van Veldhuisen DJ; Lewsey J; Frey A; Rainisio M; Kobrin I;
    JAMA; 2007 Nov; 298(17):2009-19. PubMed ID: 17986694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal effects of big endothelin-1 in experimental congestive heart failure.
    Gurbanov K; Winaver J; Haramati A; Hoffman A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S473-5. PubMed ID: 8587450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.
    Wong F; Moore K; Dingemanse J; Jalan R
    Hepatology; 2008 Jan; 47(1):160-8. PubMed ID: 17886336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the acute effects of a selective endothelin ETA and a mixed ETA/ETB receptor antagonist in heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Fukai D; Kinoshita M
    Cardiovasc Res; 1998 Sep; 39(3):617-24. PubMed ID: 9861304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant roles of endothelin-A- and -B-receptors in renal function in congestive heart failure.
    Ohnishi M; Wada A; Tsutamoto T; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S140-3. PubMed ID: 11078360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel endothelin receptor antagonist attenuates endotoxin-induced lung injury in sheep.
    Kuklin VN; Kirov MY; Evgenov OV; Sovershaev MA; Sjöberg J; Kirova SS; Bjertnaes LJ
    Crit Care Med; 2004 Mar; 32(3):766-73. PubMed ID: 15090960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac effects of endothelin receptor antagonism in endotoxemic pigs.
    Konrad D; Haney M; Johansson G; Wanecek M; Weitzberg E; Oldner A
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H988-96. PubMed ID: 17400719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelin A receptor antagonists in congestive heart failure: blocking the beast while leaving the beauty untouched?
    Spieker LE; Noll G; Ruschitzka FT; Lüscher TF
    Heart Fail Rev; 2001 Dec; 6(4):301-15. PubMed ID: 11447305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary hypertension caused by congestive heart failure is ameliorated by long-term application of an endothelin receptor antagonist. Increased expression of endothelin-1 messenger ribonucleic acid and endothelin-1-like immunoreactivity in the lung in congestive heart failure in rats.
    Sakai S; Miyauchi T; Sakurai T; Yamaguchi I; Kobayashi M; Goto K; Sugishita Y
    J Am Coll Cardiol; 1996 Nov; 28(6):1580-8. PubMed ID: 8917275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
    Gilbert C; Cherney DZ; Parker AB; Mak S; Floras JS; Al-Hesayen A; Parker JD
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(2):R167-75. PubMed ID: 26561645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant human brain natriuretic peptide on the cardiac hemodynamics and renal function in dogs with heart failure].
    Xu XW; Zeng GY; Yang Y; Liu HX
    Yao Xue Xue Bao; 2002 Oct; 37(10):758-62. PubMed ID: 12567856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
    Xia QG; Reinecke A; Dorenkamp M; Daemen MJ; Simon R; Unger T
    Acta Pharmacol Sin; 2006 Nov; 27(11):1417-22. PubMed ID: 17049116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
    Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
    Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure.
    Ding SS; Qiu C; Hess P; Xi JF; Clozel JP; Clozel M
    Cardiovasc Res; 2002 Mar; 53(4):963-70. PubMed ID: 11922906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemodynamic effects of endothelin receptor antagonist, tezosentan, in tumour necrosis factor-alpha treated anaesthetized rats.
    Tabrizchi R; Ford CA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):156-67. PubMed ID: 12595957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amlodipine therapy in congestive heart failure: hemodynamic and neurohormonal effects at rest and after treadmill exercise.
    Krombach RS; Clair MJ; Hendrick JW; Mukherjee R; Houck WV; Hebbar L; Kribbs SB; Dodd MG; Spinale FG
    Am J Cardiol; 1999 Aug; 84(4A):3L-15L. PubMed ID: 10480440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure.
    Torre-Amione G; Young JB; Colucci WS; Lewis BS; Pratt C; Cotter G; Stangl K; Elkayam U; Teerlink JR; Frey A; Rainisio M; Kobrin I
    J Am Coll Cardiol; 2003 Jul; 42(1):140-7. PubMed ID: 12849674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal effects of human urotensin-II in rats with experimental congestive heart failure.
    Ovcharenko E; Abassi Z; Rubinstein I; Kaballa A; Hoffman A; Winaver J
    Nephrol Dial Transplant; 2006 May; 21(5):1205-11. PubMed ID: 16396970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.